THE ASPIRE Mayuge trial: Recruitment Update and Interim Findings - MISSING LAST 2 MINUTES OF AUDIO

Beth Payne The ASPIRE Mayuge trial is a pragmatic, sequential, cluster randomized trial, which began recruitment in August 2019 in Mayuge, Uganda. The objective of the trial is to compare effectiveness of two models of community-based self-collected HPV testing as a screening tool for cervical cancer in this rural low-resourced setting. Arm 1 involves door-to-door recruitment of women by community health workers (CHWs). 64 CHWs were trained and 6 nurses for facility-based VIA follow-up. Over 600 women of the Arm 1 target of 1066 have been enrolled to date, with an HPV incidence of 26.7% reflecting tremendous community support and need for screening.

BC CDC Presenters

10/22/2019 6:05:00 PM